MedTrace Logo

Double Filtration Plasmapheresis (DFPP) and Lipid Metabolism

NCT03491956 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-03-17

No results posted yet for this study

Summary

Little clinic trials showed that Double Filtration Plasmapheresis (DFPP) could improve lipid metabolism, however, whether DFPP can improve platelet function and recover Endothelial function is unknown. In this study, we try to confirm the hypothesis that DFPP can improve endothelial function in hyperlipidemia patients.

Conditions

  • DFPP and Platelet Function

Interventions

DEVICE

DFPP

Lipid levels,platelet function，and platelet RNA sequencing in hyperlipidemia patients before and after DFPP

Sponsors & Collaborators

  • Shanghai Pudong Hospital

    lead OTHER

Principal Investigators

  • Bo Yu, doctor · Shanghai Pudong Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2021-04-01
Completion
2021-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03491956 on ClinicalTrials.gov